Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Covington
Chinese Patent Office
Healthtrust
QuintilesIMS
Teva
Cantor Fitzgerald
Daiichi Sankyo
Harvard Business School
Colorcon

Generated: August 17, 2017

DrugPatentWatch Database Preview

NEMBUTAL SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Nembutal Sodium, and when can generic versions of Nembutal Sodium launch?

Nembutal Sodium is a drug marketed by Oak Pharms and is included in four NDAs.

The generic ingredient in NEMBUTAL SODIUM is pentobarbital sodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.

Summary for Tradename: NEMBUTAL SODIUM

Patents:0
Applicants:1
NDAs:4
Suppliers / Packagers: see list1
Bulk Api Vendors: see list40
Clinical Trials: see list2,371
Patent Applications: see list9,802
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEMBUTAL SODIUM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms
NEMBUTAL SODIUM
pentobarbital sodium
CAPSULE;ORAL083245-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Oak Pharms
NEMBUTAL SODIUM
pentobarbital sodium
CAPSULE;ORAL084095-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Oak Pharms
NEMBUTAL SODIUM
pentobarbital sodium
INJECTABLE;INJECTION083246-001Approved Prior to Jan 1, 1982APRXNoYes► Subscribe► Subscribe► Subscribe
Oak Pharms
NEMBUTAL SODIUM
pentobarbital sodium
CAPSULE;ORAL084093-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Federal Trade Commission
Farmers Insurance
Johnson and Johnson
Julphar
Queensland Health
Medtronic
Accenture
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot